We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Bone Hormone Levels Predict Heart Failure Deaths

By LabMedica International staff writers
Posted on 22 Sep 2010
Print article
Circulating levels of a bone hormone are predictive of death and hospitalization for heart failure after acute coronary syndrome.

The level of osteoprotegerin (OPG), a member of the tumor necrosis factor receptor superfamily, can be measured using an enzyme-linked immunosorbent assay (ELISA) utilizing monoclonal antibodies.

A study OPG levels in the plasma of 1,229 patients with chronic heart failure (CHF) from 51 clinical centers, was carried out at Akershus University Hospital (Lørenskog, Norway). OPG levels were quantified by an in-house time-resolved immunofluorometric assay modified from an ELISA using commercially available monoclonal antibodies (R&D Systems; Abingdon, UK). The limit of detection for OPG was 15 ng/L.

During a median follow-up time of 3.9 years, 332 patients died and 791 patients died or were hospitalized because of cardiovascular causes. The median value of OPG was 1,509 ng/L (interquartile range: 1,102-2,185 ng/L). Circulating OPG levels were associated with a number of conventional risk markers. Patients with higher OPG levels were more likely to be older, to be female, to have more severe heart failure as evaluated by higher functional evaluation, and to have heart failure of ischemic etiology.

The main findings of this study of patients with CHF are that circulating concentrations of OPG are strongly and independently associated with all-cause mortality as well as with the incidence of the combined end point of mortality or cardio-vascular events. However, reclassification analyses suggest that the statistically significant association is unlikely to improve risk stratification of heart failure patients in a clinically meaningful way. The results showed that patients with the highest tertile of OPG were twice as likely to die during follow-up as the patients with the lowest tertile levels of OPG were.

Torbjørn Omland, M.D. Ph.D., the lead author of study, said, "The finding is interesting not only because it suggests that there is a link between bone metabolism and heart disease, but because it might help to identify heart failure patients who are at greatest risk. As medical practitioners, we can then target those patients earlier with intensified therapy.” The study was published in August 2010 issue of the American Heart Journal.

Related Links:
Akershus University Hospital
R&D Systems

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.